20:04 , Apr 25, 2019 |  BC Innovations  |  Finance

The academic founders' conundrum

First-time academic entrepreneurs face a circular problem: while they’re continually sought after by VCs and pharmas seeking the next “big thing”, they also face an arduous path to establish their bona fides - not for...
23:41 , Aug 3, 2018 |  BioCentury  |  Emerging Company Profile

Compass’ range

Compass Therapeutics LLC combines human cell display, high throughput antibody screening and a multispecific engineering platform to develop large libraries of cancer and autoimmune therapies. Traditional approaches to antibody discovery use hybridoma fusions in animals,...
18:54 , Jul 13, 2018 |  BC Week In Review  |  Financial News

With $132M series A, Compass points toward the clinic

Bispecific antibody play Compass Therapeutics LLC (Cambridge, Mass.) raised $49 million on July 12 in the final tranche of its series A round, bringing the round's total to $132 million. OrbiMed Advisers led the round....
15:35 , Jul 12, 2018 |  BC Extra  |  Financial News

With $132M series A, Compass points toward the clinic

Bispecific antibody play Compass Therapeutics LLC (Cambridge, Mass.) raised $49 million Thursday in the final tranche of its series A round, bringing the round's total to $132 million. OrbiMed Advisers led the round. F-Prime Capital...
07:00 , Aug 24, 2015 |  BC Week In Review  |  Financial News

Genalyte completes venture financing

Genalyte Inc. , San Diego, Calif.   Business: Diagnostic   Date completed: 2015-08-18   Type: Venture financing   Raised: $44 million   Investors: Khosla Ventures; Redmile Group; Claremont Creek Ventures; BioMed Realty Ventures  ...